Polydopamine nanoparticles (PDA NPs) are proposed as an anti-cancer tool against
hepatocellular carcinoma through the combination of near-infrared (NIR)-mediated …

Hepatocellular carcinoma is the most common liver malignancy and is among the top five
most common cancers. Despite the progress of surgery and chemotherapy, the results are …

Novel niosomes including cholesterol, Span (60), Tween (60), and gemcitabine (GEM) have
been developed via film hydration approach and characterized via in vitro, in vivo, and in …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer most frequently
detected at an advanced stage that limits treatment options to systemic chemotherapy, which …

Pancreatic cancer is a severe disease that threatens human health. The hypoxic tumor
microenvironment in pancreatic cancer leads to resistance to conventional therapies and …

A new class of pyrazolylmethylene-2-thioxoimidazolidin-4-one derivatives 3a–p were
rationally designed and synthesized with the aim of exploring their potential as treatments …

Acetylsalicylic acid (Aspirin) has been used for a long time as an antipyretic and analgesic.
Nevertheless, aspirin use is associated with severe morbidity and death because of its …

Nanotechnology is a possible solution to the drawbacks of cancer therapy because it
decreases the clinical side effects of chemotherapeutic drugs and increases their clinical …

Objective: Gemcitabine (GEM) is a deoxycytidine analog chemotherapeutic drug widely
used to treat many cancers. Silver nanoparticles (AgNPs) are important nanomaterials used …

Anti-angiogenic gene therapy is a promising strategy in treating cancer. Endostatin and
angiostatin are widely used in tumor anti-angiogenesis therapy. Our previous studies have …